A Review of Recent FDA-Approved Biologic-Device Combination Products

J Pharm Sci. 2024 Apr;113(4):866-879. doi: 10.1016/j.xphs.2023.12.022. Epub 2023 Dec 29.


With the remarkably strong growth of the biopharmaceutical market, an increasing demand for self-administration and rising competitions attract substantial interest to the biologic-device combination products. The ease-of-use of biologic-device combination products can minimize dosing error, improve patient compliance and add value to the life-cycle management of biological products. As listed in the purple book issued by the U.S. Food and Drug Administration (FDA), a total of 98 brand biologic-device combination products have been approved with Biologic License Application from January 2000 to August 2023, where this review mainly focused on 63 products containing neither insulin nor vaccine. Prefilled syringes (PFS) and autoinjectors are the most widely adopted devices, whereas innovative modifications like needle safety guard and dual-chamber design and novel devices like on-body injector also emerged as promising presentations. All 16 insulin products employ pen injectors, while all 19 vaccine products are delivered by a PFS. This review provides a systematic summary of FDA-approved biologic-device combination products regarding their device configurations, routes of administration, formulations, instructions for use, etc. In addition, challenges and opportunities associated with biologic-device compatibility, regulatory complexity, and smart connected devices are also discussed. It is believed that evolving technologies will definitely move the boundaries of biologic-device combination product development even further.

Keywords: Autoinjector; Biologic-device combination products; Formulation; Instructions for use; Prefilled syringe; Routes of administration.

Publication types

  • Review

MeSH terms

  • Biological Products*
  • Humans
  • Insulin
  • Self Administration
  • Syringes
  • United States
  • United States Food and Drug Administration
  • Vaccines*


  • Biological Products
  • Insulin
  • Vaccines